US Stock MarketDetailed Quotes

Cognition Therapeutics (CGTX)

Watchlist
  • 1.090
  • -0.050-4.39%
Close May 18 16:00 ET
  • 1.140
  • +0.050+4.56%
Pre 07:36 ET
97.55MMarket Cap-4.74P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cognition Therapeutics (CGTX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
43.89%-5.54M
13.65%-24.59M
59.00%-3.44M
17.52%-5.65M
6.24%-5.62M
-36.35%-9.88M
-77.76%-28.47M
-53.63%-8.38M
-64.65%-6.85M
-62.26%-6M
Net income from continuing operations
46.11%-4.57M
30.86%-23.49M
57.37%-3.34M
50.39%-4.93M
4.36%-6.73M
7.33%-8.48M
-31.73%-33.97M
3.67%-7.84M
-47.24%-9.94M
-48.98%-7.04M
Operating gains losses
--5K
-78.97%41K
----
----
----
----
--195K
--0
--0
--0
Depreciation and amortization
51.11%68K
-14.29%228K
-14.08%61K
-12.86%61K
-8.96%61K
-22.41%45K
5.56%266K
7.58%71K
7.69%70K
9.84%67K
Change In working capital
32.20%-1.38M
-368.40%-3.46M
51.62%-554K
-161.51%-1.3M
352.35%429K
-519.88%-2.03M
-73.42%1.29M
-173.97%-1.15M
46.01%2.12M
-203.57%-170K
-Change in receivables
399.52%6.27M
-415.09%-7.24M
-1,274.67%-8.02M
1,724.07%4.39M
32.66%-1.51M
-598.10%-2.09M
-158.76%-1.41M
91.32%683K
-135.76%-270K
-185.46%-2.24M
-Change in prepaid assets
-32.00%136K
-28.17%1.17M
639.06%473K
-89.96%47K
-12.55%453K
-65.69%200K
-11.83%1.63M
-92.81%64K
122.86%468K
-37.14%518K
-Change in payables and accrued expense
-9,993.33%-7.57M
89.32%3.51M
568.49%8.41M
-336.45%-5.44M
-64.41%614K
80.11%-75K
-24.02%1.85M
-397.84%-1.8M
242.56%2.3M
39.11%1.73M
-Change in other current liabilities
1.64%-60K
-28.30%-204K
-8.89%-49K
-6.82%-47K
-6.82%-47K
-134.62%-61K
-6.00%-159K
-9.76%-45K
-12.82%-44K
-29.41%-44K
-Change in other working capital
---147K
-10.08%-699K
-2,584.31%-1.37M
26.79%-246K
----
----
62.36%-635K
80.46%-51K
-130.14%-336K
89.94%-131K
Cash from discontinued investing activities
Operating cash flow
43.89%-5.54M
13.65%-24.59M
59.00%-3.44M
17.52%-5.65M
6.24%-5.62M
-36.35%-9.88M
-77.76%-28.47M
-53.63%-8.38M
-64.65%-6.85M
-62.26%-6M
Investing cash flow
Cash flow from continuing investing activities
0
325.00%9K
1,000.00%9K
0
0
0
97.28%-4K
96.67%-1K
0
83.33%-3K
Net PPE purchase and sale
--0
325.00%9K
1,000.00%9K
--0
--0
--0
97.28%-4K
96.67%-1K
--0
83.33%-3K
Cash from discontinued investing activities
Investing cash flow
--0
325.00%9K
1,000.00%9K
--0
--0
--0
97.28%-4K
96.67%-1K
--0
83.33%-3K
Financing cash flow
Cash flow from continuing financing activities
-117.98%-233K
55.19%36.57M
-94.68%605K
10,209.12%33.92M
644.93%752K
-89.19%1.3M
421.23%23.57M
366.63%11.38M
11,066.67%329K
-106.59%-138K
Net issuance payments of debt
4.24%-113K
52.23%-353K
62.05%-74K
77.84%-41K
33.70%-120K
33.71%-118K
8.88%-739K
-8.94%-195K
13.95%-185K
13.81%-181K
Net common stock issuance
--0
52.02%37.02M
-93.52%750K
6,726.76%33.93M
--877K
-88.11%1.46M
356.68%24.35M
342.17%11.58M
134.43%497K
--0
Proceeds from stock option exercised by employees
--44K
-13.41%71K
--6K
282.35%65K
--0
--0
--82K
--0
--17K
----
Net other financing activities
-256.52%-164K
-28.13%-164K
---77K
---36K
77.27%-5K
56.60%-46K
---128K
--0
--0
---22K
Cash from discontinued financing activities
Financing cash flow
-117.98%-233K
55.19%36.57M
-94.68%605K
10,209.12%33.92M
644.93%752K
-89.19%1.3M
421.23%23.57M
366.63%11.38M
11,066.67%329K
-106.59%-138K
Net cash flow
Beginning cash position
47.95%37M
-16.42%25.01M
80.92%39.82M
-59.50%11.56M
-52.62%16.43M
-16.42%25.01M
-28.01%29.92M
-33.24%22.01M
-23.28%28.53M
-10.66%34.67M
Current changes in cash
32.70%-5.78M
344.07%11.99M
-194.16%-2.82M
533.39%28.27M
20.64%-4.87M
-280.69%-8.58M
57.81%-4.91M
198.39%3M
-54.48%-6.52M
-279.12%-6.14M
Effect of exchange rate changes
----
----
----
----
----
----
--0
--0
--0
--0
End cash Position
90.07%31.23M
47.95%37M
47.95%37M
80.92%39.82M
-59.50%11.56M
-52.62%16.43M
-16.42%25.01M
-16.42%25.01M
-33.24%22.01M
-23.28%28.53M
Free cash flow
43.89%-5.54M
13.66%-24.59M
59.00%-3.44M
17.52%-5.65M
6.28%-5.62M
-36.35%-9.88M
-76.17%-28.48M
-52.81%-8.38M
-62.38%-6.85M
-61.55%-6M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 43.89%-5.54M13.65%-24.59M59.00%-3.44M17.52%-5.65M6.24%-5.62M-36.35%-9.88M-77.76%-28.47M-53.63%-8.38M-64.65%-6.85M-62.26%-6M
Net income from continuing operations 46.11%-4.57M30.86%-23.49M57.37%-3.34M50.39%-4.93M4.36%-6.73M7.33%-8.48M-31.73%-33.97M3.67%-7.84M-47.24%-9.94M-48.98%-7.04M
Operating gains losses --5K-78.97%41K------------------195K--0--0--0
Depreciation and amortization 51.11%68K-14.29%228K-14.08%61K-12.86%61K-8.96%61K-22.41%45K5.56%266K7.58%71K7.69%70K9.84%67K
Change In working capital 32.20%-1.38M-368.40%-3.46M51.62%-554K-161.51%-1.3M352.35%429K-519.88%-2.03M-73.42%1.29M-173.97%-1.15M46.01%2.12M-203.57%-170K
-Change in receivables 399.52%6.27M-415.09%-7.24M-1,274.67%-8.02M1,724.07%4.39M32.66%-1.51M-598.10%-2.09M-158.76%-1.41M91.32%683K-135.76%-270K-185.46%-2.24M
-Change in prepaid assets -32.00%136K-28.17%1.17M639.06%473K-89.96%47K-12.55%453K-65.69%200K-11.83%1.63M-92.81%64K122.86%468K-37.14%518K
-Change in payables and accrued expense -9,993.33%-7.57M89.32%3.51M568.49%8.41M-336.45%-5.44M-64.41%614K80.11%-75K-24.02%1.85M-397.84%-1.8M242.56%2.3M39.11%1.73M
-Change in other current liabilities 1.64%-60K-28.30%-204K-8.89%-49K-6.82%-47K-6.82%-47K-134.62%-61K-6.00%-159K-9.76%-45K-12.82%-44K-29.41%-44K
-Change in other working capital ---147K-10.08%-699K-2,584.31%-1.37M26.79%-246K--------62.36%-635K80.46%-51K-130.14%-336K89.94%-131K
Cash from discontinued investing activities
Operating cash flow 43.89%-5.54M13.65%-24.59M59.00%-3.44M17.52%-5.65M6.24%-5.62M-36.35%-9.88M-77.76%-28.47M-53.63%-8.38M-64.65%-6.85M-62.26%-6M
Investing cash flow
Cash flow from continuing investing activities 0325.00%9K1,000.00%9K00097.28%-4K96.67%-1K083.33%-3K
Net PPE purchase and sale --0325.00%9K1,000.00%9K--0--0--097.28%-4K96.67%-1K--083.33%-3K
Cash from discontinued investing activities
Investing cash flow --0325.00%9K1,000.00%9K--0--0--097.28%-4K96.67%-1K--083.33%-3K
Financing cash flow
Cash flow from continuing financing activities -117.98%-233K55.19%36.57M-94.68%605K10,209.12%33.92M644.93%752K-89.19%1.3M421.23%23.57M366.63%11.38M11,066.67%329K-106.59%-138K
Net issuance payments of debt 4.24%-113K52.23%-353K62.05%-74K77.84%-41K33.70%-120K33.71%-118K8.88%-739K-8.94%-195K13.95%-185K13.81%-181K
Net common stock issuance --052.02%37.02M-93.52%750K6,726.76%33.93M--877K-88.11%1.46M356.68%24.35M342.17%11.58M134.43%497K--0
Proceeds from stock option exercised by employees --44K-13.41%71K--6K282.35%65K--0--0--82K--0--17K----
Net other financing activities -256.52%-164K-28.13%-164K---77K---36K77.27%-5K56.60%-46K---128K--0--0---22K
Cash from discontinued financing activities
Financing cash flow -117.98%-233K55.19%36.57M-94.68%605K10,209.12%33.92M644.93%752K-89.19%1.3M421.23%23.57M366.63%11.38M11,066.67%329K-106.59%-138K
Net cash flow
Beginning cash position 47.95%37M-16.42%25.01M80.92%39.82M-59.50%11.56M-52.62%16.43M-16.42%25.01M-28.01%29.92M-33.24%22.01M-23.28%28.53M-10.66%34.67M
Current changes in cash 32.70%-5.78M344.07%11.99M-194.16%-2.82M533.39%28.27M20.64%-4.87M-280.69%-8.58M57.81%-4.91M198.39%3M-54.48%-6.52M-279.12%-6.14M
Effect of exchange rate changes --------------------------0--0--0--0
End cash Position 90.07%31.23M47.95%37M47.95%37M80.92%39.82M-59.50%11.56M-52.62%16.43M-16.42%25.01M-16.42%25.01M-33.24%22.01M-23.28%28.53M
Free cash flow 43.89%-5.54M13.66%-24.59M59.00%-3.44M17.52%-5.65M6.28%-5.62M-36.35%-9.88M-76.17%-28.48M-52.81%-8.38M-62.38%-6.85M-61.55%-6M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +28.67%
Sample Name
Sample Code
 +23.05%
Sample Name
Sample Code
 +22.42%
4
United Sts Brent Oil Fd Lp Unit
BNO
+21.50%
5
ProShares Ultra Energy
DIG
+19.88%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +9.81%
Sample Name
Sample Code
 +5.47%
Sample Name
Sample Code
 +3.50%
4
Hesai
HSAI
+0.96%
5
MINISO
MNSO
-0.63%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 18 Eastern Time, Trump temporarily halted the planned 'major' military strike on Iran, citing that Gulf allies requested room for neg Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -